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Diagnosis of Cancer Spread Using Percutaneous
Transhepatic Biliary Cholangioscopy-guided
Ultrasonography for Malignant Bile Duct Stenosis*
HIROKAZU INOUE*
Third Department oflnternal Medicine, Toho University School ofMedicine, Ohashi Hospital, 2-17-6, Ohashi, Meguro-ku, Tokyo 153-8515,
Japan
The characteristics of sites of intramural cancer spread were examined by comparing the
intraductal ultrasonography (IDUS) and wall thickening findings at sites of intramural cancer
spread and non-spread, in patients with malignant bile duct stenosis who had undergone
percutaneous transhepatic biliary drainage (PTBD).
The subjects were ten patients with extrahepatic bile duct cancer, two with pancreatic
cancer, one with cancer of the gallbladder, and one with cancer of the papilla of Vater who
underwent preoperative IDUS. From these patients, 50 IDUS slices were examined with a
congruent relationship with the histologic section of resected tissue. The maximum
thickening, minimum thickening, maximum/minimum thickening ratio, and form factor of the
medial and lateral margins of the medial hypoechoic layer were determined using diagnostic
imaging, and the results were compared at sites of cancer spread and non-spread.
Twelve slices were obtained from the site of stenosis, 14 from sites of cancer spread, and 24
from non-spread sites. The maximum thickening, minimum thickening, and maximum/mi-
nimum thickening ratio differed significantly between the sites of spread and the non-spread.
The absolute values for wall thickening are useful for diagnosing the presence of intramural
spread in patients with malignant biliary duct stenosis.
Keywords: Intraductal ultrasonography; Malignant bile duct stenosis; Percutaneous
transhepatic cholangioscopy; Cancer spread
INTRODUCTION
Diagnosis of the longitudinal spread of extrahepatic
bile duct cancer, particularly on the hepatic side, is
important when selecting surgical procedures, such as
resection margins, intraductal ultrasonography (IDUS)
using miniature ultrasonic probes is helpful for
diagnosing longitudinal intramural spread [1], but in
patients who have already undergone percutaneous
transhepatic biliary drainage (PTBD), localization of
the lesion is made difficult by inflammatory wall
thickening caused by the drainage tube [2,3]. The
*A summary of this paper was presented at the 35th general meeting of the Japan Biliary Association (Hiroshima, October 1999).
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purpose of this study is to compare the IDUS and wall
thickening findings at sites ofintramural cancer spread
and non-spread in patients with malignant bile duct
stenosis who had previously undergone PTBD, and
also to identify any differences between the two
methods.
PATIENTS AND METHODS
Patients
The subjects were 14 patients who underwent
preoperative IDUS, comprising of ten patients with
extrahepatic bile duct cancer, two with pancreatic
cancer, one with cancer of the gallbladder, and one
with cancer of the papilla of Vater (Table I). From
these patients, a total of 50 slices were studied at the
porta hepatis, the ends of the stenosis, the central
portion of the stenosis, the cystic duct bifurcation, and
the upper margin of the intrapancreatic bile duct, at
which sites, the ultrasound images and surgical
specimens corresponded exactly.
IDUS images were excluded if no surgical speci-
men contained the corresponding site. Also, the sites
that could not be delineated by ultrasound were
excluded because the upper margin of the intrapan-
creatic bile duct and the cystic duct bifurcation were
included in the lesion. Slices from the central portion
of the stenosis, and on the duodenal side of this were
excluded in two patients in whom the probe could not
be advanced to the distal side due to the severity of
stenosis.
Test Methods
A CHF-T20 scope used for percutaneous transhepatic
cholangioscopy (diameter of forceps’ opening:
2.6mm, Olympus Optical, Tokyo, Japan), a UM3R
ultrasound probe (outer diameter of tip: 2.4mm,
maximum diameter: 2.5mm, 20MHz, Olympus
Optical), and an EUM20 drive unit (Olympus Optical)
were used. Endoscopy, fluoroscopy, and ultrasono-
graphy were simultaneously performed while observ-
ing the procedure on a television monitor. During
cholangioscopy, the biliary tract was instilled with
saline through the instrumentation channel, and it was
ensured that the bile duct and the endoscopic image
could be matched at all times while injecting contrast
medium as required. The UM3R miniature ultrasonic
probe was passed through the instrumentation channel
of the CHF-T20 cholangioscope under endoscopic
guidance, and IDUS was performed while watching
the procedure on the monitor. The still ultrasound
images were retained as appropriate, and the entire
process was recorded on a video tape recorder.
Image Analysis
TheIDUS images were analyzedby feeding eachimage
into an EM-1,2 two-dimensional manual measurement
TABLE Subjects
Patient no. Anatomical regions pTNM pathological classification Stage grouping
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
Extrahepatic bile ducts
Extrahepatic bile ducts
Extrahepatic bile ducts
Extrahepatic bile ducts
Extrahepatic bile ducts
Extrahepatic bile ducts
Extrahepatic bile ducts
Extrahepatic bile ducts
Extrahepatic bile ducts
Extrahepatic bile ducts
Head of pancreas
Head of pancreas
Gallbladder
Papilla of Vater
pT3N1M0
pT3NOM0
pT3NIM0
pT2NOM0
pT2NOM0
pT3NIM0
pT2NOM0
pT3NOM0
pT3NOM0
pT3NOM0
pT2N1M0
pT3N1M0
pT2N1M0
pT3N1M0
IVA
IVA
IVA
II
II
IVA
II
IVA
IVA
IVA
III
III
III
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program (Rise, Miyagi, Japan), tracing the contours
with a digitizer, and measuring the maximum and
minimum thickening and the maximum/minimum
thickening ratio of the medial hypoechoic layer in the
slice (Fig. 1). The uniformity of the medial and lateral
margins of the medial hypoechoic layer was also
calculated using the formula for the form factor, an
indicator of the degree of marginal unevenness (form
factor perimeter x perimeter/area 1/47r). The term
"perimeter" means the lateral margin or medial margin
in Fig. 1. The form factor for a circle is one and increases
as the unevenness and deformitybecomes moremarked.
significance of differences, and differences were
considered to be significant, when p < 0.05.
RESULTS
The mean time between PTBD and IDUS was 23.4
days and ranged from 8 to 42 days. The 50 slices were
divided into three groups based on the degree of
histopathological spread in the corresponding speci-
mens: sites of intramural spread (14 slices), sites of
intramural non-spread (24 slices), and the central
portion of the stenosis (12 slices) (Table II).
Histological Diagnosis
The entire surgical specimen was cut at 5mm
intervals, and after determining the extent of cancer
spread, hematoxylin and eosin stained specimens at
the sites corresponding to the ultrasound images were
examined again by microscopy to determine the
presence or absence of cancer infiltration.
Analysis of Measured Values
Fifty of the IDUS slices were to be compared with the
tissue specimens. These were divided into three
groups, comprising sites of cancer spread, non-spread
sites, and the central portion of the stenosis, and the
IDUS findings for each group were compared. The
Mann-Whitney U-test was used to assess the
lateral margin
Thickening of Medial Hypoechoic Layer
At sites of cancer spread, the mean maximum
thickening was 3.4mm (range: 1.5-5.3), the mean
minimum thickening was 1.3mm (0.5-2.2), and the
mean maximum/minimum thickening ratio was 2.7
(1.1-4.5). At sites of non-spread, the mean maximum
thickening was 1.7 mm, (0.7-2.9), the mean mini-
mum thickening was 1.0mm (0.5-2.1), and the mean
maximum/minimum thickening ratio was 1.9 (1.3-
3.3). At the site of stenosis, the mean maximum
thickening was 4.4mm (2.7-6.6), the mean minimum
thickening was 1.6mm (0.8-2.6), and the mean
maximum/minimum thickening ratio was 3.0 (2.1-
4.3). The maximum thickening, minimum thickening,
and maximum/minimum thickening ratio, all differed
significantly between the sites of cancer spread and
non-spread (Table III).
medial margin
Uniformity of the Medial Hypoechoic Layer
FIGURE A frame from intraductal ultrasonography showed
probe in the bile duct within ultrasonography field of view. A:
maximum thickening of the medical hypoechoic layer; B: minimum
thickening of the medial hypoechoic layer.
At sites of cancer spread, the mean form factor was
1.76 (1.32-2.62) for the medial margin and 1.50
(1.21-1.73) for the lateral margin. At sites of non-
spread, the mean form factor was 1.81 (1.31-4.15) for
the medial margin and 1.57 (1.33-2.23) for the lateral
margin. The mean form factor for the lateral margin at
the site of stenosis was 1.83 (1.38-2.54). There were
no significant differences between the sites of cancer162 H. INOUE
TABLE II Fifty slices of IDUS
No. of cases
Site of intramural spread:
Positive 14
Negative 24
Central portion of the stenosis 12
spread and non-spread with respect to the uniformity
of either the medial or lateral margin (Table IV).
Accuracy of Assessment of Cancer Spread Based
on Wall Thickening
When cancer-spread-positive was defined in terms of
the thickening of the medial hypoechoic layer, based
on the fact that there was a difference between sites of
cancer spread and non-spread with respect to the
thickening of this layer, and the sensitivity and
specificity were calculated per 0.1 mm, a thickening
of 2mm produced the best results. Overall, the
sensitivity of a thickening of 2mm for an accurate
cancer-positive diagnosis was 85.7%, and the
specificity was 66.7% (Table V).
DISCUSSION
Diagnosis of the longitudinal spread of extrahepatic
bile duct cancer on the hepatic side is important when
deciding on surgical procedures, such as resection
margins [4-6]. In a study of surgical bile duct cancer
specimens, Shimada et al. noted that cancer spread on
the hepatic side comprises superficial and intramural
spread, and that they are not necessarily consistent.
They found a mean 16.8mm difference in the distance
of spread between the two. In other words, superficial
and intramural spreads need to be considered
separately, when diagnosing cancer spread on the
hepatic side. Cholangioscopy is useful for diagnosing
superficial spread, and its diagnostic accuracy is
improved, when combined with endoscopic fine
needle biopsy [7]. However, endoscopy is only useful
for diagnosing superficial spread; it does not provide
an accurate indication of intramural spread. Intra-
mural spread has traditionally been assessed using
cholangiography. However, the accuracy of direct
cholangiography for diagnosing spread on the hepatic
side is limited. Taki et al. found that cholangiography
was only 67% accurate for assessing the extent of
cancer infiltration, even though the study was
conducted retrospectively [8]. Recent studies have
investigated the clinical application of miniature
ultrasonic probes [9], and these are now used for
diseases of the biliary tract. With these probes, IDUS
can be used to examine the inside of the bile duct wall
and to diagnose various biliary diseases [1,10,11].
Tamada et al. found that IDUS was more useful than
direct cholangiography for diagnosing bile duct
cancer spread on the hepatic side, with accuracies of
70 and 56%, respectively, [12].
The increasing focus on more detailed testing using
IDUS has led to improvements, including the develop-
ment of probes that can pass through the forceps’
channel of endoscopes, the use of higher frequencies,
and the development of models employing guide wires
[13-15]. IDUS can be conducted using either a
transpapillary approach or a percutaneous transhepatic
approach. With the transpapillary approach, the probe is
either inserted directly using the same technique by
TABLE III Thickness for medial hypoechoic layer
A B
(mm) (mm) MB ratio
Site of intramural spread
Central portion of the stenosis
Positive (n 14) 3.4 (1.5-5.3)* 1.3 (0.5-2.2)** 2.7 (1.1-4.5)*
Negative (n 24) 1.7 (0.7-2.9)* 1.0 (0.5-2.1)** 1.9 (1.3-3.3)*
(n 12) 4.4 (2.7-6.6) 1.6 (0.8-2.6) 3.0 (2.1-4.3)
Values are expressed as mean (range:minimum-maximum).
p < 0.01 **p < 0.05 by two-tailed Mann-Whitney U-test. A: maximum of the thickness for the medial hypoechoic layer; B: minimum of the thickness for the
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TABLE IV Form factor
Medial margin Lateral margin
Site of intramural spread
Central portion of the stenosis
Positive (n 14)
Negative (n 24)
(n-- 12)
1.76 (1.32-2.62) n.s.
1.81 (1.31-4.15) n.s.
1.50 (1.21-1.73) n.s.
1.57 (1.33-2.23) n.s.
1.83 (1.38-2.54)
Values are expressed as mean (range:minimum-maximum).
Two-tailed Mann-Whitney U-test. n.s.: no significant difference.
TABLE V Diagnostic results by the thickness of the medical hypoechoic layer
Positive
Site of intramural spread
Negative
All slices (n 38) ->2mm 13 7
<2mm 17
Sensitivity 85.7% Specificity 66.7%
which the contrast medium tube is selectively inserted
into the bile duct from the forceps’ channel of the
duodenoscope orby passing it overa guide wire retained
in the bile duct 13-15]. Once inserted into the bile duct,
the probe can be moved freely in and out in a vertical
direction, but since the probe is maneuvered blindly, the
region of interest cannot be scanned at will. Instead, it
was decided to use the percutaneous transhepatic
approach because the probe can be maneuvered more
easily. The advantage of this approach is that the probe
can be moved as desired because scanning can be
performed under endoscopic guidance. In other words,
the positional relationship between the lesion and the
probe can be accurately determined, and slight
adjustments can be made to the probe position by
bending the cholangioscope. However, the percuta-
neous transhepatic approach requires forming a route of
access for PTBD. The average time between the
formation of a fistula from the puncture and IDUS was
23.4 days. Inflammatory wall thickening may occur if
the tube is left in place for a prolonged period and
frequently presents a problem for diagnostic imaging.
Definite wall thickening usually occurs approximately 2
weeks afterPTBD tube insertion [2,3] and is a problem
because it is difficult to distinguish between wall
thickening caused by cancer infiltration and inflamma-
tory wall thickening.
The present study is conducted to determine whether
inflammatory wall thickening caused by the PTBD tube
might play a role in the diagnosis of longitudinal cancer
spread in patients with malignant bile duct cancer. Other
authors have noted that wall thickening caused by
intramural cancer infiltration is unilateral and that the
medial margin is often uneven [16-18]. Non-uniform
wall thickening was quantified by measuring the
maximum thickening, minimum thickening, and the
maximum/minimum thickening ratio of the medial
hypoechoic layer, and the results at sites of cancer
spread and non-spread were compared. Findings
revealed an appreciable significant difference in the
maximum and minimum values between the two sites.
The thickening ofthe medical hypoechoic layer (i.e. the
wall thickening findings) is therefore an important
factor in the diagnosis of cancer infiltration.
The uniformity of the medial and lateral margins of
the medial hypoechoic layer was quantified by tracing
the contours and calculating the form factor as an
indicator of the extent of unevenness. However, it was
not possible to discriminate based on margin
configuration because there was no significant
difference between the sites of cancer spread and
non-spread.A previous study found that it was possible
to discriminate histologically on the basis of the
configuration of the medial and lateral margins [19],
and from this study, it was noted that a non-uniform
medial margin is associated with cancer infiltration.
Therefore further studies using other quantitative
analysis are needed.164 H. INOUE
Since the thickening of the medial hypoechoic layer
is important in the diagnosis of cancer infiltration, as
mentioned earlier, thickening was investigated and its
diagnostic accuracy was calculated for cancer infiltra-
tion per 0.1 mm. The best results were obtained using a
thickening of 2mm (Table V), and the sensitivity and
specificity using this value were found to be
satisfactory. The fact that the specificity was lower
than the sensitivity was probably due to a high false-
positive rate, since a previous study reported a mean
thickness of 2.0mm for the medial hypoechoic layer of
bile duct wall showing inflammatory thickening due to
tube placement [2]. Thickening of the medial
hypoechoic layer of 2mm or greater that is continuous
with the central portion of the stenosis should therefore
be used as an indication of the extent of cancer
infiltration in patients with malignant bile duct stenosis.
CONCLUSIONS
This study shows that the absolute values for medial
hypoechoic layer thickening are useful for diagnosing
the presence of intramural cancer infiltration from
IDUS images, and that thickening of the medial
hypoechoic layer of 2mm or greater, that is continuous
with the central portion of the stenosis should be
considered to represent the extent of cancer infiltration.
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